#
Update: TF-Scan Pilot Study
Dec 10, 2024
Summary of the results of the Talus pilot project and their potential impact.
#
Behind the Scenes - Tapscott Lab
Nov 18, 2024
Behind the scenes at the Tapscott Lab at the Fred Hutchinson Cancer Center in Seattle.
#
Update: Uncovering the genetic drivers and suppressors of DUX4 in FSHD
Nov 15, 2024
Final grant report.
#
Report: The role of macrophages in Facioscapulohumeral muscular dystrophy
Nov 8, 2024
Dr. Nunes' initial project report.
#
Report: Mapping Facioscapulohumeral muscular dystrophy through single nuclei RNA sequencing
Nov 6, 2024
Initial progress report.
#
Report: Molecular Markers of FSHD
Nov 2, 2024
The mid-year progress report for Dr. Stephen Tapscott’s project.
#
Update: Motor Outcomes to Validate Evaluations in FSHD
Aug 4, 2024
MOVE FSHD study update.
#
Progress Update: Flex fund for clinical study participant reimbursement
Jul 11, 2024
Patient study update by Dr. Kyba after a Covid hiatus.
#
Progress Update: Consequence of human satellite II repeat expression in FSHD
Jun 27, 2024
Findings indicate selective interactions of RNA binding proteins with HSATII RNA, which may impact mRNA processing pathways downstream of DUX4 expression; and that HSATII RNA structure dictates protein recruitment.
#
World FSHD Day - Interview with Rick & Terry
Jun 20, 2024
FSHD Straight Talk: 2024 World FSHD Special!
#
Report: Molecular Markers of FSHD
May 30, 2024
First year progress.
#
Report: Kennedy Krieger Institute Data-Lake Expansion
May 18, 2024
The progress report highlights advancements in constructing an MRI data-lake for studying Facioscapulohumeral Muscular Dystrophy (FSHD) using AI segmentation techniques.
#
Report: Mini-Pig Atlas Development
May 18, 2024
Finalizing biopsy fiducial details to ensure correspondence between histology, DUX4, and MRI data, with atlas generation to begin in earnest in the summer of 2024.
#
Update: Uncovering the genetic drivers and suppressors of DUX4 in FSHD
May 16, 2024
Developing a comprehensive understanding of DUX4 gene regulation.
#
Exploring the interaction between mitochondrial dynamics and autophagy: can we counteract accumulation of dysfunctional mitochondria in FSHD muscle?
Apr 23, 2024
Understanding how FSHD cells differ in autophagy and mitophagy will allow one to identify the key mechanisms involved in this metabolic dysregulation of the disease and identify potential therapeutics. Dr. Heher provides a 6-month update on his work so far.
#
Update: Understanding Global Genetic Diversity in FSHD and Building International Trial Readiness
Mar 17, 2024
Dr. Bugiardini provides the first update to comprehensively understanding global genetic diversity in FSHD.
#
Update: Motor Outcomes to Validate Evaluations in FSHD
Feb 17, 2024
An update on the MOVE FSHD study.
#
Progress Update: Novel Therapeutics for FSHD: Mitochondria-targeted Antioxidants
Feb 17, 2024
Dr. Heher's final report on very interesting data regarding oxidative stress.
#
MDA Announces Recipient of 2024 Legacy Award for Achievement in Research is Jeffrey Chamberlain, Ph.D.
Feb 1, 2024
Dr. Chamberlain is honored by the MDA with the 2024 Legacy Award for Achievement in Research.
#
Progress Update: Consequence of human satellite II repeat expression in FSHD
Jan 30, 2024
Dr. Arends provides an update to current work.